Skip to main content

Featured

OAS Just Got Its Biggest Raise of 2026: What 1.4% Actually Pays

  Canadian Money Brief • Published October 2, 2026 Old Age Security is going up 1.4% for the October-to-December quarter, the biggest of the four quarterly adjustments in 2026. For a senior on the maximum pension, that works out to $10.53 more a month . Whether that feels like a raise or just a catch-up depends on a number most headlines skip: how much prices have risen over the past year. +$10.53 a month Maximum OAS for ages 65 to 74 goes from $751.97 to $762.50. That is about $126 more over a year, and it starts with the Oct. 28 deposit. What actually changes on October 28 The new rate applies to the Oct. 28 payment and the two after it (Nov. 26 and Dec. 22). Nothing needs to be filed. It applies to OAS, the Guaranteed Income Supplement (GIS) and the Allowances automatically. Maximum monthly amount Jul–Sep 2026 Oct–Dec 2026 Change OAS, ages 65 to 74 $751.97 $762.50 +$10.53 OAS, age 75 and over $827.17 $838.75 +$11.58 GIS, single senior (approx.) $1,123.17 about $1,138.89 about +$...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment